FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Search FDA Site | A-Z Index | Contact FDA

horizonal rule

Dockets Management

Dockets Entered On June 12, 2003

TABLE OF CONTENTS (Linked)

Docket # Title
   
1995S-0158 Community Disclosure of Institutional Review Boards
1996N-0417 CGMP in Mfg. Packing or Holding Dietary Supplements
   
1999P-2547 Alendronate Sodium Tablets
2000P-1322 Food Labeling and Allergen Contamination Control
   
2002D-0526 Guidance for drug Chemistry, Manufacturing, Control Info.
2002N-0204 Bar Code Label Requirements for human drug products
   
2002P-0363 NDA 20-560: Fosamax (Alendronate Sodium Tablets)
2002P-0493 Anti-heart burn drug Omeprazole magnesium (brand Prilosec1)
2003D-0044 Reporting Results for Studies Evaluating Diagnostic Tests
2003N-0069 FDA Task Force on Consumer Health Info for Better Nutrition
2003N-0143 Continued Over-the-Counter Status of Ipecac Syrup
2003N-0224 Premarket Notification for Food Contact Substances; Public Meeting
2003P-0108 Permit ANADA for Apramycin Sulfate Soluble Powder
CONTENTS
1994P-0036 Req labeling of trans fatty acid & prohibit deceptive claims
C 2609 Ray Thelen Vol #: 72
1995S-0158 Community Disclosure of Institutional Review Boards
RPT 11 University of Washington Vol #: 19 Additional Material
1996N-0417 CGMP in Mfg. Packing or Holding Dietary Supplements
C 118 Peter M. & John C. Family Dentistry Vol #: 17
C 119 K&K Laboratories, Inc. Vol #: 17
C 120 Tobin Drug Vol #: 17
C 121 Enzymatic Therapy Natural Medicines Vol #: 17
TR 4 Transcript of 4/29/2003 public Stakeholder Meeting Vol #: 19 Word
Pages 1-99 pdf
Pages 100-190. pdf
TR 5 Transcript of 5/06/2003 Public Stakeholder Meeting Vol #: 20 Word
Pages 1-100.pdf
Pages 101-169.pdf
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
C 6525 I. F. Taylor Vol #: 280
C 6526 Cynthia Pedersen Vol #: 280
C 6527 Bill Albertin Vol #: 280
C 6528 Gale Watts Vol #: 280
C 6529 Ann Campbell Vol #: 280
C 6530 Paul C. Szabo Vol #: 280
C 6531 Mr. & Mrs. Lee Spinosa Vol #: 280
C 6532 D. Belanger Vol #: 280
C 6533 no signature Vol #: 280
C 6534 Sylvia Berzins Vol #: 280
C 6535 Bernice Dobrosy Vol #: 280
C 6536 Mary Wicks Vol #: 280
C 6537 Florence Francis Vol #: 280
C 6538 Celia McKenzie Vol #: 280
C 6539 Sherill L. Stedham Vol #: 280
C 6540 Lucille DiBattista Vol #: 280
C 6541 Elaine L. Somers Vol #: 280
C 6542 Susana Sanchez Galtieri Vol #: 280
C 6543 E. Borggren Vol #: 280
C 6544 Beverly Matuszewski Vol #: 280
C 6545 Mrs. Wm. Livingston Vol #: 280
C 6546 Jesse Bair Vol #: 280
C 6547 Lorraine Stacy Vol #: 280
C 6548 Anne P. Taylor Vol #: 280
C 6549 Greta & Gerald Deutsch Vol #: 280
C 6550 Eileen Baldwin Vol #: 280
C 6551 Betty James Vol #: 280
C 6552 Patricia D. Woolley Vol #: 280
C 6553 Joann De Laine Vol #: 280
EMC 3202 Susan Nauslar Vol #: 281
EMC 3203 Janet Stoner Vol #: 281
EMC 3204 Karienne Gauthier Vol #: 281
EMC 3205 Cheryl Fisher Vol #: 281
EMC 3206 Melissa Maroff Vol #: 281
EMC 3207 Neil Edwards Vol #: 281
EMC 3208 Stacy & Michael Berlin Vol #: 281
EMC 3209 Dani Starr Vol #: 281
1999P-2547 Alendronate Sodium Tablets
LET 2 HFD-1 to Merck & Co., Inc. Vol #: 1
2000P-1322 Food Labeling and Allergen Contamination Control
 
C 531 The Food Allergy Network Vol #: 30
2001P-0230 Domestic Marketing & Importation of Transgenic Fish
C 1331 Rebecca D'Angelo Vol #: 233
C 1332 Diane Taudvin Vol #: 233
C 1333 Sandi Navarro Vol #: 233
C 1334 Harriet Gohr Vol #: 233
EMC 2723 Bill & Marilyn Voorhies Vol #: 228
EMC 2724 Crystal A. Baker Vol #: 228
EMC 2725 J. Farrell Vol #: 228
EMC 2726 Erik McMillan Vol #: 228
EMC 2727 Lisamarie McGrath Vol #: 228
EMC 2728 Andrew McGrath Vol #: 228
EMC 2729 Laura Southcott Vol #: 228
EMC 2730 Richard Smith Vol #: 228
EMC 2731 Nikki Sexton Vol #: 228
2002D-0526 Guidance for drug Chemistry, Manufacturing, Control Info.
C 2 Harry L. Welles, PhD Vol #: 1
2002N-0204 Bar Code Label Requirements for human drug products
C 50 Eli Lilly and Company Vol #: 14
C 51 Alpharma Vol #: 14
C 52 FEI Products, LLC (FEI) Vol #: 14
C 53 American Hospital Assn (AHA) Vol #: 14
C 54 Air Products Healthcare Vol #: 14
C 55 Greater New York Hospital Assn (GNYHA) Vol #: 14
C 56 Council on Radionuclides and Radiopharmaceuticals (CORAR) Vol #: 14
C 57 Gas Regs, Inc. Vol #: 14
C 58 American Assn for Homecare (AAHomecare) Vol #: 14
C 59 Thomson Healthcare, Inc. Vol #: 14
C 60 VISI Subcommittee Vol #: 14
C 61 Baxter Healthcare Corporation (Baxter) Vol #: 14
C 62 US Pharmacopeia Vol #: 14
C 63 Plasma Protein Therapeutics Assn Vol #: 14
C 64 Johnson & Johnson Vol #: 14
C 65 National Alliance for Health Information Technology (the Alliance) Vol #: 14
C 66 Cardinal Health Vol #: 14
C 67 DocuSys Vol #: 14
C 68 Ohio State University Vol #: 14
C 69 C.B. Fleet Company, Inc. Vol #: 14
C 70 Pharmaceutical Printed Literature Assn (PPLA) Vol #: 14
C 71 Fresenius USA Manufacturing, Inc. Vol #: 14
C 72 Passport Homecare, Inc. Vol #: 14
C 73 Pharmaceutical Research and Manufacturers of America (PhRMA) Vol #: 14
C 74 Federation of American Hospitals Vol #: 14
C 75 Abbott Laboratories Vol #: 14
C 76 American Society of health-System Pharmacists (ASHP) Vol #: 14
C 77 Colorcon, Inc. Vol #: 14
C 78 Hollister-Stier Laboratories, LLC (Hollister-Stier) Vol #: 14
C 79 Bristol-Myers Squibb Vol #: 14
C 80 Generic Pharmaceutical Assn Vol #: 14
C 81 AstraZeneca Vol #: 14
C 82 Healthcare Leadership Council (HLC) Vol #: 14
C 83 American Society of Consultant Pharmacists Vol #: 14
C 84 American HomePatient (AHOM) Vol #: 14
C 85 West Tennessee Healthcare Vol #: 14
C 86 Premier, Inc. Vol #: 14
EC 73 Schoneker, David Vol #: 17
EC 74 Holmberg, Jerry Vol #: 17
EC 75 Ayres, Katharine I. Vol #: 17
EC 76 Harder, Joel Vol #: 17
EC 77 Harder, Joel Vol #: 17
EC 79 Tarnove, Lorraine Vol #: 17
EC 80 Shreve, Gina Vol #: 17
2002N-0276 Bioterrorism Preparedness;Registration of Food Facilities
MM 12 FDA and Formatta Corporation Vol #: 13
2002P-0363 NDA 20-560: Fosamax (Alendronate Sodium Tablets)
LET 2 HFD-1 to Merck & Co., Inc. Vol #: 1
2002P-0493 Anti-heart burn drug Omeprazole magnesium (brand Prilosec1)
RC 1 Andrx Pharmaceutical Co. Vol #: 1
2003D-0044 Reporting Results for Studies Evaluating Diagnostic Tests
C 6 Dade Behring, Inc. Vol #: 1
2003N-0069 FDA Task Force on Consumer Health Info for Better Nutrition
C 3 American Dietetic Assn (ADA) Vol #: 1 Additional Material
C 4 Center for Science in he Public Interest Vol #: 1
2003N-0143 Continued Over-the-Counter Status of Ipecac Syrup
C 1 Humco Holding Group, Inc. Vol #: 1
2003N-0224 Premarket Notification for Food Contact Substances; Public Meeting
NM 1 FDA Vol #: 1
2003P-0108 Permit ANADA for Apramycin Sulfate Soluble Powder
PAV 1 HFV-100 to Bimeda, Inc. Vol #: 1

Page Updated July 1, 2003

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility